No Data
A Glimpse Into The Expert Outlook On Integra Lifesciences Through 8 Analysts
Analysts' ratings for Integra Lifesciences (NASDAQ:IART) over the last quarter vary from bullish to bearish, as provided by 8 analysts.The table below summarizes their recent ratings, showcasing the e
Integra LifeSciences Price Target Cut to $40.00/Share From $49.00 by JMP Securities
Integra LifeSciences Price Target Cut to $40.00/Share From $49.00 by JMP Securities
Integra's (IART) Q1 Earnings Match Estimates, Margins Down
Integra LifeSciences Holdings Corporation IART delivered adjusted earnings per share (EPS) of 55 cents in the first quarter of 2024, down 25.7% year over year.
Oppenheimer Cuts Integra to Perform, Cites Boston Plant Delays
Integra LifeSciences Cut to Equal-Weight From Overweight by Wells Fargo
Integra LifeSciences Cut to Equal-Weight From Overweight by Wells Fargo
Wells Fargo Downgrades Integra Lifesciences to Equal-Weight, Lowers Price Target to $25
Wells Fargo analyst Vik Chopra downgrades Integra Lifesciences (NASDAQ:IART) from Overweight to Equal-Weight and lowers the price target from $45 to $25.